$TNXP Income Statement | Understand Stock

$TNXP

$5.39 +$0.09 (1.7%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
REVENUES:
Total product revenues
COSTS AND EXPENSES:
Cost of sales
Research and development
General and administrative
Selling, general and administrative
Asset impairment charges
Total Operating Expenses

Operating loss
Grant income
Gain on change in fair value of warrant liabilities
Loss on extinguishment of debt
Interest income
Net loss
Preferred stock deemed dividend
Interest expense
Other expense, net
Net loss available to common stockholders
Net loss per common share, basic and diluted
Weighted average common shares outstanding, basic and diluted
Net loss to common stockholders per common share, basic
Net loss to common stockholders per common share, diluted
Weighted average common shares outstanding, basic
Weighted average common shares outstanding, diluted

Comments